{"": [132, 1019, 0, 1020, 1043, 0, 1044, 2721, 0, 2722, 3434, 0, 3435, 4192, 0, 4193, 5178, 0], "Study design and participants": [5200, 5810, 0], "Procedures": [5811, 8406, 0], "Detection of anti-SARS-CoV-2 S1 IgG antibodies in serum": [8407, 9789, 0], "Outcomes": [9790, 10441, 0], "Statistical analysis": [10442, 11084, 0], "Materials & methods": [5179, 11084, 1], "Primary outcomes": [12949, 15416, 0], "Seroconversion according to anticancer therapy": [15417, 17492, 0], "Long-term outcomes (after 3\u00a0months)": [17493, 19387, 0], "Safety": [19388, 20358, 0], "COVID-19 infection after vaccination": [20359, 21482, 0], "Results": [11085, 21482, 1], "Discussion": [21483, 27972, 0], "Conclusion": [27973, 28872, 0]}